The Kratom Council

Latest / Regulation

Regulation

North Dakota Convenes A Special Session On Kratom Today. The Two Bills In Front Of It Point In Opposite Directions.

Two squared stacks of plain paper on a bare oak table, photographed from overhead, each angled toward an opposite corner of the frame.

North Dakota's 141 legislators convene at the State Capitol in Bismarck today for a special session called, in substantial part, to decide what the state does about kratom. It is the second special session the Legislature has held this year — the first time in the state's history that has happened.

Five bills made the agenda out of roughly twenty pieces of legislation submitted for consideration. Two of them are about kratom, and they do not point the same direction. One would regulate the natural leaf and leave it on shelves under conditions. The other would ban synthetic derivatives outright and attach criminal penalties. Between them sits the same question every state has been answering differently for two years.

This report is written before the vote. What follows is what is on the floor, not what comes off it.

How North Dakota Got Here

The state's position on kratom has moved further and faster than almost anywhere else, and not in a straight line.

In the 2025 regular session, the Legislature considered banning the plant and declined decisively: the measure failed in the House 15 to 77. That is not a close vote. Sixteen months later, Governor Kelly Armstrong banned kratom outright by executive order on August 3, and then called the Legislature back into session to address it — a sequence in which the executive acted first and asked the legislative branch to sort out the durable version afterward.

A working group advanced bill drafts through August. Members of the public turned out to comment in the days immediately before the session. The session itself is expected to cost the state more than $200,000.

Bill One: Regulate The Leaf Like Tobacco

Representative Pat Heinert, a Bismarck Republican, has proposed adopting regulations for natural kratom products modeled on the state's existing framework for tobacco.

By the accounts of its reporting, the bill would prohibit sale to anyone under 21, create labeling requirements including a warning that the product may be addictive, and empower the attorney general to regulate kratom sales in the state.

That is recognizably the Kratom Consumer Protection Act model that industry advocates have pressed for in other states: age-gate it, label it, give an enforcement authority jurisdiction over it, and leave the leaf lawful. It is also, structurally, an argument that the problem is an unregulated market rather than the plant.

Bill Two: Ban The Derivatives, With Criminal Penalties

Senator Michelle Axtman, also a Bismarck Republican, has proposed a ban on synthetic derivatives of kratom — 7-hydroxymitragynine among them — written to reach derivatives that reach the market in future as well. The bill is reported to include criminal penalties for use and possession of those derivatives.

Two features are worth flagging for readers who have followed the federal track. The first is the forward-looking construction: a ban written to cover successor compounds is an attempt to solve at state level the problem the DEA addressed federally in August, when it scheduled three 7-OH analogs that had appeared after 7-OH itself came under proposal. The second is that criminal penalties for use and possession reach further than most state measures in this area, which have tended to target sale and distribution.

This publication has not obtained the bill text and reports its contents as described in coverage of the working group's drafts. Anyone relying on the specifics should read the enrolled version.

The Fork, Again

Set together, the two bills are the national argument in miniature.

One says the leaf and its concentrated derivatives are different things and should be treated differently — regulate one, prohibit the other. That is the line federal policy has drawn so far: the pending DEA proposal reaches 7-OH above a concentration threshold, and the Food and Drug Administration has stated it is “not intended to apply to natural kratom leaf containing only naturally occurring trace levels of 7-OH.”

The other position — the one the August executive order took — is that the distinction is too fine to administer and the plant should simply be prohibited. Nine states have reached that conclusion. North Dakota reached it by executive action a month ago and is now asking its Legislature whether to keep it.

What makes today unusual is that both answers are on the same floor, on the same day, in a state that voted 15 to 77 against prohibition sixteen months ago and then imposed it by order anyway.

What This Publication Will Be Watching

Whether both bills pass, one passes, or neither does. Whether the regulation bill's age, labeling and enforcement provisions survive intact or get amended toward something stricter. Whether the derivatives ban keeps its criminal penalties for use and possession, which is the provision most likely to draw objection. And whether whatever passes displaces the executive order or sits alongside it.

The federal picture behind all of this has not moved. The DEA's temporary scheduling order on 7-OH above a threshold has still not issued as of this publication's most recent verified check, more than four weeks after the statutory minimum elapsed on August 5. The related federal comment window closes September 10. States are not waiting for either.

This publication will report the outcome when the session produces one.

Sources

  1. InForum — "North Dakota governor calls special session to ban kratom"
  2. Valley News Live — "Bills for kratom regulation, synthetic ban advance to North Dakota special session" (August 18, 2026)
  3. InForum — "20 pieces of legislation submitted for historic North Dakota special session targeting kratom"
  4. Jamestown Sun — "5 bills make it to North Dakota special session"
  5. InForum — "Second special session expected to cost North Dakota more than $200K"
  6. KFYR-TV — "Public voices their opinions ahead of legislative special session on kratom" (September 2, 2026)
  7. MPR News — "North Dakota banned Kratom and set a special session for September"
  8. Federal Register — DEA notice of intent on 7-hydroxymitragynine above a specified threshold, Docket No. DEA-1570 (July 6, 2026)
  9. The Kratom Council — "North Dakota Advances Two Kratom Bills Ahead of a September Special Session" (August 26, 2026)
  10. The Kratom Council — "The Council Answers: What The August 26 Scheduling Order Actually Covers — And What It Does Not"

← Back to all coverage

Get new reporting by email